Article
Molecular diagnosis of diffuse glioma using a chip-based digital PCR system to analyze IDH, TERT, and H3 mutations in the cerebrospinal fluid.
Journal of neuro-oncology - 1 Mar 2021
Fujioka Yutaka, Hata Nobuhiro, Akagi Yojiro, Kuga Daisuke, Hatae Ryusuke, Sangatsuda Yuhei, Michiwaki Yuhei, Amemiya Takeo, Takigawa Kosuke, Funakoshi Yusuke, Sako Aki, Iwaki Toru, Iihara Koji, Mizoguchi Masahiro
Abstract excerpt
PURPOSE: Conventional genetic analyzers require surgically obtained tumor tissues to confirm the molecular diagnosis of diffuse glioma. Recent technical breakthroughs have enabled increased utilization of cell-free tumor DNA (ctDNA) in body fluids as a reliable resource for molecular diagnosis in various cancers. Here, we tested the application of a chip-based digital PCR system for the less invasive diagnosis...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
